PL438038A1 - Sposób określenia ryzyka raków u kobiet w zależności od wieku, historii palenia oraz stężenia selenu we krwi - Google Patents
Sposób określenia ryzyka raków u kobiet w zależności od wieku, historii palenia oraz stężenia selenu we krwiInfo
- Publication number
- PL438038A1 PL438038A1 PL438038A PL43803821A PL438038A1 PL 438038 A1 PL438038 A1 PL 438038A1 PL 438038 A PL438038 A PL 438038A PL 43803821 A PL43803821 A PL 43803821A PL 438038 A1 PL438038 A1 PL 438038A1
- Authority
- PL
- Poland
- Prior art keywords
- blood
- cancer
- age
- smoking
- history
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Inorganic Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Przedmiotem zgłoszenia jest sposób określenia ryzyka zachorowania na raka u kobiet niepalących papierosów, powyżej 60 roku życia, charakteryzujący się tym, że obejmuje ilościową ocenę stężenia selenu we krwi osoby badanej, przy czym stężenie wskazuje na ponad 3 krotnie zmniejszone ryzyko zachorowania na raka w stosunku do podgrupy ze stężeniem selenu we krwi poniżej 94 µg/l lub > 104 µg/l, w przypadku występowania wartości stężenia selenu we krwi w przedziale 94 — 104 µg/l.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL438038A PL438038A1 (pl) | 2021-06-01 | 2021-06-01 | Sposób określenia ryzyka raków u kobiet w zależności od wieku, historii palenia oraz stężenia selenu we krwi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL438038A PL438038A1 (pl) | 2021-06-01 | 2021-06-01 | Sposób określenia ryzyka raków u kobiet w zależności od wieku, historii palenia oraz stężenia selenu we krwi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL438038A1 true PL438038A1 (pl) | 2022-12-05 |
Family
ID=84426789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL438038A PL438038A1 (pl) | 2021-06-01 | 2021-06-01 | Sposób określenia ryzyka raków u kobiet w zależności od wieku, historii palenia oraz stężenia selenu we krwi |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL438038A1 (pl) |
-
2021
- 2021-06-01 PL PL438038A patent/PL438038A1/pl unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hariton et al. | Anti-Müllerian hormone levels among contraceptive users: evidence from a cross-sectional cohort of 27,125 individuals | |
| Carlsen et al. | Effects of ejaculatory frequency and season on variations in semen quality | |
| Lindblad et al. | Sense of coherence is a predictor of survival: A prospective study in women treated for breast cancer | |
| Abdollah et al. | Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis. | |
| Lassemillante et al. | Prevalence of osteoporosis in prostate cancer survivors II: a meta-analysis of men not on androgen deprivation therapy | |
| Glynn et al. | Measuring concurrency: an empirical study of different methods in a large population-based survey and evaluation of the UNAIDS guidelines | |
| Marino et al. | Sexual inactivity in partnered female cancer survivors | |
| Zilioli et al. | The impact of negative family–work spillover on diurnal cortisol. | |
| Yeap et al. | Lower plasma testosterone or dihydrotestosterone, but not estradiol, is associated with symptoms of intermittent claudication in older men | |
| Krysiak et al. | Sexual function and depressive symptoms in young women with overt hyperthyroidism | |
| Bansal et al. | A prospective study of anti‐mullerian hormone and other ovarian and adrenal hormones in adult female acne | |
| Marteinsdottir et al. | Parity‐related variation in cortisol concentrations in hair during pregnancy | |
| Zaslavsky et al. | Association of dynamics in lean and fat mass measures with mortality in frail older women | |
| PL438038A1 (pl) | Sposób określenia ryzyka raków u kobiet w zależności od wieku, historii palenia oraz stężenia selenu we krwi | |
| Dehaghi et al. | Non-auditory effects of industrial chronic noise exposure on workers; change in salivary cortisol pattern | |
| Karmisholt et al. | Detecting true change in the hospital anxiety and depression scale, SF-36, and hypothyroid score when monitoring patients with subclinical hypothyroidism | |
| Ramesh et al. | Thyroid eye disease: pilot study comparison between patients in United States-based and India-based practices | |
| Parimi et al. | Hair as biomarker of fluoride exposure in a fluoride endemic area and a low fluoridated area | |
| Meani et al. | Incidence of vulval squamous cell carcinoma in women with vulval lichen sclerosus in an Australian tertiary referral centre. | |
| Tritschler et al. | Usefulness of D-dimer testing in predicting recurrence in elderly patients with unprovoked venous thromboembolism | |
| PL433150A1 (pl) | Sposób określenia ryzyka raków u kobiet z mutacją BRCA1 w zależności od stężenia ołowiu we krwi | |
| PL437896A1 (pl) | Sposób określenia ryzyka raków u mężczyzn w zależności od stężenia arsenu we krwi | |
| PL437898A1 (pl) | Sposób określenia ryzyka raków u mężczyzn w zależności od stężenia selenu we krwi | |
| PL438655A1 (pl) | Sposób określenia ryzyka raków u kobiet w zależności od stężenia ołowiu we krwi | |
| PL437897A1 (pl) | Sposób określenia ryzyka raków u mężczyzn w zależności od stężenia kadmu we krwi |